File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.xpro.2022.101921
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Article: Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma
Title | Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma |
---|---|
Authors | |
Issue Date | 1-Dec-2022 |
Publisher | Cell Press |
Citation | STAR Protocols, 2022, v. 3, n. 4 How to Cite? |
Abstract | Here, we present a detailed protocol for the identification of potential oncofetal targets for hepatocellular carcinoma (HCC) patients through a hepatocyte differentiation model and a sorafenib refractory cell-line-derived xenograft model. We describe the procedures of tumor sphere formation, organoid generation, and subcutaneous tumor formation for functional studies. We then detail the procedures of immunohistochemistry and immunofluorescence for examination of changes in lineage-specific markers. Finally, we describe the development of antibody-based therapeutics targeting tumor lineage plasticity in HCC. |
Persistent Identifier | http://hdl.handle.net/10722/328536 |
ISSN | 2023 Impact Factor: 1.3 2023 SCImago Journal Rankings: 0.955 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Li, Mei Mei | - |
dc.contributor.author | Kong, Fan En | - |
dc.contributor.author | Li, Guang Meng | - |
dc.contributor.author | He, Yi Ti | - |
dc.contributor.author | Zhang, Xiao Feng | - |
dc.contributor.author | Zhang, Cheng Yang | - |
dc.contributor.author | Liang, Jie Kai | - |
dc.contributor.author | Guan, Xin Yuan | - |
dc.contributor.author | Ma, Ning Fang | - |
dc.contributor.author | Xie, Mao Bin | - |
dc.contributor.author | Liu, Ming | - |
dc.date.accessioned | 2023-06-28T04:45:55Z | - |
dc.date.available | 2023-06-28T04:45:55Z | - |
dc.date.issued | 2022-12-01 | - |
dc.identifier.citation | STAR Protocols, 2022, v. 3, n. 4 | - |
dc.identifier.issn | 2666-1667 | - |
dc.identifier.uri | http://hdl.handle.net/10722/328536 | - |
dc.description.abstract | <p>Here, we present a detailed protocol for the identification of potential oncofetal targets for hepatocellular carcinoma (HCC) patients through a hepatocyte differentiation model and a sorafenib refractory cell-line-derived xenograft model. We describe the procedures of tumor sphere formation, organoid generation, and subcutaneous tumor formation for functional studies. We then detail the procedures of immunohistochemistry and immunofluorescence for examination of changes in lineage-specific markers. Finally, we describe the development of antibody-based therapeutics targeting tumor lineage plasticity in HCC.<br></p> | - |
dc.language | eng | - |
dc.publisher | Cell Press | - |
dc.relation.ispartof | STAR Protocols | - |
dc.title | Identification and functional characterization of potential oncofetal targets in human hepatocellular carcinoma | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.xpro.2022.101921 | - |
dc.identifier.hkuros | 344667 | - |
dc.identifier.volume | 3 | - |
dc.identifier.issue | 4 | - |
dc.identifier.eissn | 2666-1667 | - |
dc.identifier.issnl | 2666-1667 | - |